Oncolytics Biotech Inc. (ONCY) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.02
Day's range
$1.09

Oncolytics Biotech, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MARSHALL WACE, LLP 08/13/2026 745.35 K $708.08 K   -13.31% 0.62%
XTX TOPCO LTD 08/14/2026 260.90 K $247.83 K   100.00% 0.22%
SEEDS INVESTOR LLC 08/12/2026 258.31 K $245.37 K   100.00% 0.22%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 07/22/2026 201.26 K $181.28 K   100.00% 0.17%
CONNECTIVE CAPITAL MANAGEMENT, LLC 08/13/2026 185.71 K $176.41 K   100.00% 0.16%
GOLDMAN SACHS GROUP INC 08/14/2026 169.90 K $161.39 K   100.00% 0.14%
TOCQUEVILLE ASSET MANAGEMENT L.P. 08/10/2026 147.00 K $139.64 K   100.00% 0.12%
EVERHART FINANCIAL GROUP, INC. 07/09/2026 140.90 K $133.84 K   100.00% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 134.13 K $127.41 K   100.00% 0.11%
PFG INVESTMENTS, LLC 07/23/2026 128.30 K $121.87 K   100.00% 0.11%
HRT FINANCIAL LP 08/14/2026 126.33 K $119.00 K   100.00% 0.11%
INVESCO LTD. 08/14/2026 101.20 K $96.13 K   100.00% 0.08%
DOLIVER ADVISORS, LP 07/10/2026 100.00 K $94.99 K   100.00% 0.08%
LPL FINANCIAL LLC 08/07/2026 80.32 K $76.29 K   100.00% 0.07%
FRANKLIN RESOURCES INC 08/13/2026 79.84 K $75.84 K   100.00% 0.07%
CIBC WORLD MARKET INC. 08/13/2026 69.30 K $65.83 K   100.00% 0.06%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 66.94 K $63.59 K   100.00% 0.06%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 62.01 K $58.90 K   100.00% 0.05%
ROYAL BANK OF CANADA 08/14/2026 57.41 K $55.00 K   100.00% 0.05%
FIFTH THIRD BANCORP 08/05/2026 45.53 K $43.25 K   100.00% 0.04%
HEADINVEST, LLC 08/14/2026 44.70 K $42.46 K   100.00% 0.04%
BADGLEY PHELPS WEALTH MANAGERS, LLC 07/31/2026 40.00 K $38.00 K   100.00% 0.03%
CLEARSTEAD ADVISORS, LLC 08/06/2026 39.00 K $37.05 K   100.00% 0.03%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 08/14/2026 36.50 K $34.67 K   100.00% 0.03%
RAYMOND JAMES FINANCIAL INC 08/14/2026 36.09 K $34.28 K   100.00% 0.03%
SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/ 09/18/2026 33.26 K $31.59 K   100.00% 0.03%
COMMONWEALTH EQUITY SERVICES, LLC 07/29/2026 35.11 K $33.35 K   100.00% 0.03%
CATALYST FUNDS MANAGEMENT PTY LTD 08/10/2026 31.68 K $30.09 K   100.00% 0.03%
NATIONAL BANK OF CANADA /FI/ 08/10/2026 31.54 K $29.59 K   100.00% 0.03%
UBS GROUP AG 08/13/2026 31.10 K $29.54 K   100.00% 0.03%
VANTAGE POINT FINANCIAL LLC 08/14/2026 29.74 K $28.25 K   100.00% 0.02%
CITIGROUP INC 08/03/2026 29.22 K $27.76 K   100.00% 0.02%
BANK OF AMERICA CORP /DE/ 08/14/2026 25.00 K $23.73 K   100.00% 0.02%
MORGAN STANLEY 08/13/2026 21.77 K $20.67 K   100.00% 0.02%
STONEBRIDGE FINANCIAL GROUP, LLC/CA 08/13/2026 21.06 K $20.00 K   100.00% 0.02%
TRUIST FINANCIAL CORP 07/28/2026 20.00 K $19.00 K   100.00% 0.02%
PROFESSIONAL ADVISORY SERVICES INC 07/08/2026 20.00 K $19.00 K   100.00% 0.02%
CITADEL ADVISORS LLC 09/02/2026 19.81 K $18.82 K   100.00% 0.02%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 19.70 K $18.72 K   100.00% 0.02%
BLAIR WILLIAM & CO/IL 08/11/2026 15.20 K $14.44 K   100.00% 0.01%
PNC FINANCIAL SERVICES GROUP, INC. 08/07/2026 15.06 K $14.30 K   100.00% 0.01%
TWO SIGMA SECURITIES, LLC 08/14/2026 14.86 K $14.12 K   100.00% 0.01%
Y-INTERCEPT (HONG KONG) LTD 07/14/2026 13.29 K $12.62 K   100.00% 0.01%
VICTORY CAPITAL MANAGEMENT INC 08/07/2026 13.51 K $12.83 K   100.00% 0.01%
CREATIVE PLANNING 08/13/2026 13.50 K $12.82 K   100.00% 0.01%
ALPHACORE CAPITAL LLC 08/06/2026 12.50 K $11.87 K   100.00% 0.01%
CONCURRENT INVESTMENT ADVISORS, LLC 07/27/2026 12.50 K $11.87 K   100.00% 0.01%
VALLEY NATIONAL ADVISERS INC 07/29/2026 12.00 K $11.40 K   100.00% 0.01%
AUSDAL FINANCIAL PARTNERS, INC. 08/14/2026 12.00 K $11.40 K   100.00% 0.01%
KINGSVIEW WEALTH MANAGEMENT, LLC 08/19/2026 11.21 K $10.65 K   100.00% 0.01%

Oncolytics Biotech, Inc. institutional Ownership - FAQ's

During the previous two years, 96 institutional investors and hedge funds held shares of Oncolytics Biotech, Inc.. The most heavily invested institutionals were:

MARSHALL WACE, LLP: 745,350

XTX Topco Ltd: 260,903

SEEDS INVESTOR LLC: 258,306

INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC: 201,260

Connective Capital Management, LLC: 185,712

GOLDMAN SACHS GROUP INC: 169,898

3.54% of Oncolytics Biotech, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 4.46 M shares in the last 24 months. This purchase volume represents approximately $4.73 M in transactions.